Statistics about Health, Pharma & Medtech in United States
Statistics
- U.S. dollar share of the leading parasite treatment brands 2019
- Side-effects comparison marijuana vs. prescription medicine U.S. 2017
- Revenue, expenses and startup costs for medical marijuana dispensaries U.S. 2017
- Diagnoses at physicians visits for benzodiazepines U.S. 2014-2016
- Use of prescription opioid analgesic among U.S. adults by age and gender 2007-2012
- U.S. adults who heard of opioids by ethnicity 2017
- U.S. medical cannabis patient-selected negative side effects as of 2017
- U.S. medical cannabis physician perceived benefits as of 2017
- U.S. medical cannabis patient-selected most important benefits as of 2017
- Addictiveness comparison marijuana vs. prescription medicine U.S. 2017
- Drugs in development for autoimmune diseases in the U.S. 2016 by all types
- U.S. NIH investments in cannabis research FY 2015
- Drugs U.S. adults had used to relieve gastrointestinal problems 2017
- Rate of opioid use disorder in insured US persons by dosage and duration 2015
- Wholesale price of U.S. medical cannabis 2018, by state
- Reasons for consumption of opioids by U.S. adults by age group 2017
- U.S. adults who tried homeopathy by community type 2017
- growth in 90 day prescriptions U.S. 2013-2020
- U.S. adults who tried homeopathy by annual income 2017
- U.S. adults who tried homeopathy by age group 2017
- U.S. marijuana and common stimulants-substances retail market size 2016
- U.S. veterans of Iraq and Afghanistan who had used medical cannabis as of 2018
- U.S. share of revenue-generating marijuana businesses being profitable 2016
- U.S. adults who tried osteopathy by annual income 2017
- Price disparities for top product Tamiflu - U.S. and international 2017
- U.S. adults who tried homeopathy 2017
- Medication-assisted treatment prevalence of insured persons U.S. 2010-2016, by type
- U.S. medical marijuana dispensaries open 2015, by state
- U.S. adults who were prescribed unnecessary amount of opioids 2017
- Leading autoimmune disease products U.S. 2016, by sales
- Opioid use disorder rate in commercially-insured persons U.S. 2016, by gender and age
- Actual need of opioids for everyone who is prescribed by age group US 2017
- U.S. adults who tried osteopathy by age group 2017
- Clinical trial costs by select component and phase
- 20 most abused prescription drugs in the U.S. by revenue 2016
- Medical cannabis production licenses in the U.S. 2018, by state
- U.S. patients beliefs on opioid and OTC pain medication 2019
- Increase in research collaborations between 2005 and 2014 U.S. by type
- Price disparities for Zetia - U.S. and international 2017
- Average number of approved ANDAs per month in U.S. 2009-2017
- Leading skin care categories in the U.S. 2014
- U.S. states which approved specific diseases for treatment with marijuana
- Rheumatoid arthritis treatment market value U.S. 2013 and 2020
- Production licenses per medical cannabis retailer in the U.S. 2018, by state
- Total per-study costs by clinical trial phase and therapeutic area
- Flow of payments for a 400 USD insulin with high deductible patient 2017
- Leading home health care categories in the United States 2014 by unit sales
- Drug preference among U.S. adults with gastrointestinal problems 2017, by age
- Population per U.S. medical cannabis retailer 2018, by select state
- Price disparities for top product Nasonex - U.S. and international 2017
- U.S. consumer feelings about direct-to-consumer pharmaceutical ads in 2017
- Drug preference among U.S. adults with gastrointestinal problems 2017
- U.S. adults who took prescribed opioids by age group 2017
- Number of U.S. medical cannabis retail licenses 2018, by state
- Medicare Part B and Part D spending on advertised drugs 2016-2018
- Opinions on cannabis use in conjunction with nonopioids in U.S. patients as of 2017
- Personalized medicine in development by type 2015
- Share of U.S. opioid consumers who consumed prescribed opioids 2017
- Concern for antibiotic resistance among U.S. adults 2018 vs. 2020
- U.S. cannabis patents issued since 1976, by category
- Share of patients for which a certain drug is ineffective by therapy class
- Opinions on opioid policies for U.S. cancer patients 2019, by political affiliation
- Dietary supplement types used by 40 to 59-year-olds in the U.S. 2017-2018
- Drugs U.S. adults had used to relieve gastrointestinal problems 2017, by age
- Opinions on alternative treatments for cancer U.S. 2019, by political affiliation
- U.S. adults who took opioids in last 2 years 2017
- Reasons for consumption of opioids by U.S. adults 2017
- Cancer treatments used by U.S. adults with cancer experience last 12 months 2019
- Prescription opioid/marijuana access difficulty among U.S. cancer patients 2019
- Unnecessary antibiotic use for acute respiratory conditions in the U.S. 2015, by age
- Medical marijuana efficacy for managing symptoms among U.S. cancer patients 2019
- Share of 90 day prescriptions that are mail or retail dispensed 2013-2020
- Anxiety among U.S. cancer patients regarding their financial situation 2019
- Percentage of unnecessary antibiotic prescriptions in the U.S. in 2015, by age
- Average per-study costs by trial phase
- Drug spending in the U.S. 2013-2017, by specialty and orphan status
- FDA on breakthrough therapy requests by therapy area 2019
- Unsuccessful attempts and new drugs for cancer types 1998-2014
- Americans preferring Advil pain reliever in Q1 2016 and 2017, by region
- U.S. legal medical marijuana patients rate by state 2018
- U.S. adults share with positive view on alternative medicine by community 2017
- U.S. adults with positive views on alternative medicine by income 2017
- U.S. adults with positive views on alternative medicine by ethnicity 2017
- Opinion of US adults on "opioid epidemic" as an expression by age group 2017
- Penetration rate of U.S. medical cannabis by select state 2018
- U.S. adults who feared addiction to opioids by age group 2017
- Opioid prescriptions for U.S. insured persons by gender and age 2015
- U.S. adults who were prescribed unnecessary amount of opioids 2017, by gender
- Opinions on cannabis use in conjunction with opioids among U.S. patients as of 2017
- Number of medicines in development for heart disease and stroke by type 2018
- Opinion of US adults on opioid epidemic as an expression 2017
- U.S. number of marijuana businesses in 2017
- Cumulative price change of orphan drugs in the U.S. 2012-2014
- U.S. adults who who feared addiction to opioids 2017
- U.S. adults opinion on responsibility for high consumption of opioids 2017
- Generics share of prescription spending in the U.S. by formulation 2012 vs. 2017
- Dietary supplement types used by adults 60 years and older in the U.S. 2017-2018
- Morphine equivalents: oral solid opioids share in U.S. by drug 2010-2017
- Medicare spending on advertised and non-advertised drugs 2016-2018
- Share of market revenue Rx oral solid opioids by drug in U.S. 2017